On 25th October 2017, MDS Alliance Members bombarded the Twitter world with the MDS topic, something that had never been done before. MDS AWARENESS DAY 2017 SOCIAL MEDIA CAMPAIGN The plan was simple: to share facts on #MDSSM, and nominate others in same twitter post. The campaign lasted for 25 hours, starting at 11pm on…
A one-off specialist consultation should be offered to all newly diagnosed patients
By Patrick Festy – Read the whole article and join the conversation in MDSEUROPE, a blog for MDS stakeholders, part of the MDS-RIGHT programme. What do we mean by fatigue? When questioned about our disease, we and our doctors speak first of fatigue, but most words that are used — weariness, tiredness, numbness, heavy legs, stiff…
Update on the work around the ERN European Reference Networks. Thursday, July 28, 2016 The 21st Congress of the European Hematology Association ( June 9-12, 2016) was abuzz with networking between over 10.000 participants who travelled from all over the world to Copenhagen. The EHA Congress combined sessions and a diverse range of topics…
CATCH UP ONLINE: ASH DECEMBER 2016 Abstracts presented at recent annual meetings of the American Society of Hematology are available online. Have a look at the abstracts here. You can also watch the videos of the highlights of the 2016 conference from ASH News TV Top Takeaways Day 2 Highlights Day 3 Highlights > PAST AND…
Supporting patients and families affected by Myelodysplastic Syndromes through education, advocacy, and community support. Together, we provide hope and resources for the MDS journey.
© 2026 MDS Alliance. All rights reserved.
Overview Mode: Shows all countries at once with color-coded treatment availability.
Details Mode: Click the “Details” button to see individual treatment maps. Select any treatment from the list to view its availability by country.
Color Legend:
Navigation:
If you have data about treatment access in your country that you’d like to share, please contact us using the form below or email us directly.
Email: [email protected]
We are particularly interested in:
Your contributions help us maintain accurate and up-to-date information for the MDS community worldwide.
